[ Rapid Medical raises $9M in Series B ]

Rapid Medical  has raised $9 million in Series B funding.

Founded in 2008, Rapid Medical is developing game-changing devices for endovascular treatments. Rapid Medical is the maker of TIGERTRIEVER, the first-ever controllable, fully visible stentriever that is designed to treat ischemic stroke patients

The new financing will be used to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh.

Funding  Series B
Founded  2008
Country  South Korea
City  Yongam, Cholla-namdo
Founder / CEO  Ronen Eckhouse
Deal Size  $9M
Investors  Shanghai-Israel Investment Fund
 BRM Group
 Gefen Capital
Previous Investors  /